Abstract:You have accessJournal of UrologyProstate Cancer: Basic Research & Pathophysiology II1 Apr 2018MP64-10 INFILTRATING CD4+ T CELLS ATTENUATED THE SENSITIVITY OF CHEMOTHERAPY IN PROSTATE CANCER VIA SECRETING CCL5 Peng Xiang, Shuai Hu, Song Jin, Yang Yang, JingDong Sheng, and Jie Jin Peng XiangPeng Xiang More articles by this author , Shuai HuShuai Hu More articles by this author , Song JinSong Jin More articles by this author , Yang YangYang Yang More articles by this author , JingDong ShengJingDong Sheng More articles by this author , and Jie JinJie Jin More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.2055AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Management of castration-resistant prostate cancer (CPRC) remains challenging because of the unavoidable emergence of acquired resistance to chemotherapy with docetaxel(Doc). The tumor immune micro-environment as well as their secreted cytokines and growth factors play a substantial role in tumor survival and development of resistance to chemotherapy. Our early study have proved that CD4(+)T cells in prostate tumor micro-environment contribute to prostate cancer(PCa) progression, however, their effects on PCa chemo-sensitivity remained unclear. METHODS CD4+T cell infiltration from post-chemotherapy paraffin embedded specimens was performed by IHC. CRPC cell lines--C4-2, CWR22RV1 and CD4(+) T cell lines--HH and Molt-3 were used in vitro co-culture system. After 48 hours co-culture, the PCa cell chemo-sensitivity were detected by CCK8, Tunel and Western-blot. Various cell cytokine was determined by Cytokine arrays and QPCR. RESULTS We found more CD4+T cell infiltration in tumor area (Figure 1A) than in adjacent normal prostate (Figure 1B) in clinical samples. After co-culture with the CD4+T cells, C4-2 and 22Rv1 cells become more resistant to Doc treatment in a dose-dependent manner ranging from 1 nM to 8 nM (Figure 2A). Tunel results indicated that CD4+T cells protect PCa cells from Doc-induced apoptosis (Figure 2C). Meanwhile, the level of cleaved PARP, another indicator for the apoptotic process were also decreased (Figure 2B). QPCR and Cytokine arrays indicates that after co-culture with PCa CD4+T cells could secrete a significantly higher CCL5 (Figure 3A). Moreover, CCL5 stimulation enhanced PCa resistance to docetaxel(Figure 3B). Anti-ccl5 neutralization antibody could reverse co-culture PCa resistance to docetaxel. CONCLUSIONS CD4+T cells significantly attenuated prostate cancer chemo-sensitivity in vitro. Additionally, CCL5 secreted by CD4+T cells plays a key factor in chemo-therapy resistance. © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e853-e854 Advertisement Copyright & Permissions© 2018MetricsAuthor Information Peng Xiang More articles by this author Shuai Hu More articles by this author Song Jin More articles by this author Yang Yang More articles by this author JingDong Sheng More articles by this author Jie Jin More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Sensitization of radio-resistant prostate cancer cells with a unique cytolethal distending toxin

Cytolethal Distending Toxin Enhances Radiosensitivity in Prostate Cancer Cells by Regulating Autophagy

Drug-Tolerant Cancer Cells Show Reduced Tumor-Initiating Capacity: Depletion of Cd44(+) Cells and Evidence for Epigenetic Mechanisms

δ-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles

Establishment and Characterization of a Docetaxel-Resistant Human Prostate Cancer Cell Line.

Infiltrating CD4+ T cells attenuate chemotherapy sensitivity in prostate cancer via CCL5 signaling

Microwave triggered multifunctional nanoplatform for targeted photothermal-chemotherapy in castration-resistant prostate cancer

Cytosine Deaminase-Overexpressing hTERT-Immortalized Human Adipose Stem Cells Enhance the Inhibitory Effects of Fluorocytosine on Tumor Growth in Castration Resistant Prostate Cancer

Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1

Inhibition Of Ezh2 By Chemo- And Radiotherapy Agents And Small Molecule Inhibitors Induces Cell Death In Castration-Resistant Prostate Cancer

MP64-10 INFILTRATING CD4+ T CELLS ATTENUATED THE SENSITIVITY OF CHEMOTHERAPY IN PROSTATE CANCER VIA SECRETING CCL5

Inhibition of Cathepsin D (CTSD) Enhances Radiosensitivity of Glioblastoma Cells by Attenuating Autophagy

Overcoming ABCB1 mediated multidrug resistance in castration resistant prostate cancer

The Antitumor Effects Of Cik Cells Combined With Docetaxel Against Drug-Resistant Lung Adenocarcinoma Cell Line Spc-A1/Dtx In Vitro And In Vivo

Carboxylesterase-overexpressing hTERT-immortalized human adipose stem cells in prostate tumor growth inhibition by irinotecan

Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy

Androgen deprivation-induced senescence confers sensitivity to a senolytic strategy in prostate cancer

In Situ Transduction of Cytosine Deaminase Gene Followed by Systemic Use of 5-Fluorocytosine Inhibits Tumor Growth and Metastasis in Orthotopic Prostate Cancer Mouse Models

Decreased Dab2ip Gene Expression, Which Could Be Induced By Fractionated Irradiation, Is Associated With Resistance To Gamma-Rays And Alpha-Particles In Prostate Cancer Cells

C-Met Inhibitor SU11274 Enhances the Response of the Prostate Cancer Cell Line DU145 to Ionizing Radiation.

Activated CD4+ T Cells As Radiosensitizer: Enhancement of Irradiation-Induced Cytotoxicity by Pretreatment of Tumor Cell with Activated CD4+ T Cells